|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM283307498 |
003 |
DE-627 |
005 |
20240716231903.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2018 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.201800106
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1472.xml
|
035 |
|
|
|a (DE-627)NLM283307498
|
035 |
|
|
|a (NLM)29682821
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Wang, Weizhi
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Molecular Cancer Imaging in the Second Near-Infrared Window Using a Renal-Excreted NIR-II Fluorophore-Peptide Probe
|
264 |
|
1 |
|c 2018
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 07.03.2019
|
500 |
|
|
|a Date Revised 16.07.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
|
520 |
|
|
|a In vivo molecular imaging of tumors targeting a specific cancer cell marker is a promising strategy for cancer diagnosis and imaging guided surgery and therapy. While targeted imaging often relies on antibody-modified probes, peptides can afford targeting probes with small sizes, high penetrating ability, and rapid excretion. Recently, in vivo fluorescence imaging in the second near-infrared window (NIR-II, 1000-1700 nm) shows promise in reaching sub-centimeter depth with microscale resolution. Here, a novel peptide (named CP) conjugated NIR-II fluorescent probe is reported for molecular tumor imaging targeting a tumor stem cell biomarker CD133. The click chemistry derived peptide-dye (CP-IRT dye) probe afforded efficient in vivo tumor targeting in mice with a high tumor-to-normal tissue signal ratio (T/NT > 8). Importantly, the CP-IRT probes are rapidly renal excreted (≈87% excretion within 6 h), in stark contrast to accumulation in the liver for typical antibody-dye probes. Further, with NIR-II emitting CP-IRT probes, urethra of mice can be imaged fluorescently for the first time noninvasively through intact tissue. The NIR-II fluorescent, CD133 targeting imaging probes are potentially useful for human use in the clinic for cancer diagnosis and therapy
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a molecular imaging
|
650 |
|
4 |
|a peptide probe
|
650 |
|
4 |
|a renal-excretion
|
650 |
|
4 |
|a second near-infrared window
|
650 |
|
4 |
|a tumor targeting
|
650 |
|
7 |
|a Fluorescent Dyes
|2 NLM
|
650 |
|
7 |
|a Peptides
|2 NLM
|
700 |
1 |
|
|a Ma, Zhuoran
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhu, Shoujun
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wan, Hao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yue, Jingying
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ma, Huilong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ma, Rui
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yang, Qinglai
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Zihua
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Qian
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Qian, Yixia
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yue, Chunyan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Yuehua
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Fan, Linyang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhong, Yeteng
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhou, Ying
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gao, Hongpeng
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ruan, Junshan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hu, Zhiyuan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liang, Yongye
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Dai, Hongjie
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 30(2018), 22 vom: 02. Mai, Seite e1800106
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
773 |
1 |
8 |
|g volume:30
|g year:2018
|g number:22
|g day:02
|g month:05
|g pages:e1800106
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.201800106
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 30
|j 2018
|e 22
|b 02
|c 05
|h e1800106
|